These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 14744975)

  • 1. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L
    Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.
    Hirschfield GM; Gallimore JR; Kahan MC; Hutchinson WL; Sabin CA; Benson GM; Dhillon AP; Tennent GA; Pepys MB
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8309-14. PubMed ID: 15919817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?
    Reifenberg K; Lehr HA; Baskal D; Wiese E; Schaefer SC; Black S; Samols D; Torzewski M; Lackner KJ; Husmann M; Blettner M; Bhakdi S
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1641-6. PubMed ID: 15920030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice.
    Schwedler SB; Amann K; Wernicke K; Krebs A; Nauck M; Wanner C; Potempa LA; Galle J
    Circulation; 2005 Aug; 112(7):1016-23. PubMed ID: 16087790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency.
    Bodary PF; Shen Y; Vargas FB; Bi X; Ostenso KA; Gu S; Shayman JA; Eitzman DT
    Circulation; 2005 Feb; 111(5):629-32. PubMed ID: 15668341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
    Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.
    Ortiz MA; Campana GL; Woods JR; Boguslawski G; Sosa MJ; Walker CL; Labarrere CA
    Exp Biol Med (Maywood); 2009 Jun; 234(6):624-31. PubMed ID: 19359657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen species.
    Schwedler SB; Kuhlencordt PJ; Ponnuswamy PP; Hatiboglu G; Quaschning T; Widder J; Wanner C; Potempa LA; Galle J
    Atherosclerosis; 2007 Dec; 195(2):e76-84. PubMed ID: 17669410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
    Trion A; de Maat MP; Jukema JW; van der Laarse A; Maas MC; Offerman EH; Havekes LM; Szalai AJ; Princen HM; Emeis JJ
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1635-40. PubMed ID: 15920036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
    Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.
    Ozaki M; Kawashima S; Yamashita T; Hirase T; Namiki M; Inoue N; Hirata K; Yasui H; Sakurai H; Yoshida Y; Masada M; Yokoyama M
    J Clin Invest; 2002 Aug; 110(3):331-40. PubMed ID: 12163452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
    Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
    Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.
    Torzewski M; Reifenberg K; Cheng F; Wiese E; Küpper I; Crain J; Lackner KJ; Bhakdi S
    Thromb Haemost; 2008 Jan; 99(1):196-201. PubMed ID: 18217154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
    Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
    Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
    Alp NJ; McAteer MA; Khoo J; Choudhury RP; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):445-50. PubMed ID: 14707037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
    Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
    J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice.
    She ZG; Zheng W; Wei YS; Chen HZ; Wang AB; Li HL; Liu G; Zhang R; Liu JJ; Stallcup WB; Zhou Z; Liu DP; Liang CC
    Circ Res; 2009 May; 104(10):1160-8. PubMed ID: 19359600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
    Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
    Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.